Zivo Bioscience, Inc.·4

Jan 5, 4:51 PM ET

Marchiando Keith 4

4 · Zivo Bioscience, Inc. · Filed Jan 5, 2021

Insider Transaction Report

Form 4
Period: 2021-01-01
Marchiando Keith
Chief Financial Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2021-01-01+13,000,00013,000,000 total
    Exercise: $0.14Exp: 2030-12-31Common Stock (13,000,000 underlying)
Footnotes (1)
  • [F1]3,000,000 vested immediately, and 1,250,000 shares will vest on each six month anniversary of the date of grant.

Documents

2 files